Intelligent Veterinary Implants
About the Company
TraceRay Oy was established in April 2015 as a spin-off from the research activities at the University of Turku. The company designs and manufactures novel intelligent bioactive implants for small and large animals and post-operative care products.
Product Line
Bioactive bioresorbable TTA osteotomy wedge
The novel bioactive bioresorbable TTA implant consists of a gradually resorbing load-bearing shell which encompasses a rapidly resorbing casing loaded with silica-based bioactive glass (BG) granulate. The shell and the casing are manufactured from biodegradable polymers by 3D printing. The BG granulate stimulates osteogenesis and prophylaxes bacterial infections. The casing is expected to resorb within days after the surgery. After 6 months, when the wedge is completely permeated by the newly formed bone, the load-bearing capacity of the shell of the implant is no longer required and the shell will resorb and be excreted from the body. The application of the TTA implant is not restricted to a certain surgical procedure and can be transformed according to surgeon's expectations. In addition, standard surgical instrumentation can be used with the TraceRay TTA implant.
Novel bone fracture fixation system
The novel fracture fixation plate takes advatage of cutting-edge composite technology. It is semi-flexible and allows contouring to the shape of the bone. Thereafter, the plate is stiffened in situ. The system has two main functions: 1. it acts as a load-bearing fracture fixation plate and 2. delivers therapeutics to the fracture site.
Contact Information
Email: info@traceray.com
Tel. +358449749183
Address: Werstas Pharmacity, Itäinen Pitkäkatu 4C, 20520 Turku, Finland
Supported by